Long-Acting Multifunctional Antiviral Agents
InvestorsAbout Us
viIMMUNE is an emerging biopharmaceutical company dedicated to the discovery and commercialization of innovative antiviral drugs. As a clinical stage company, exploits small molecules as inhibitors of different enzymes in pathogenic viruses life cycle. Our mission at viIMMUNE is to help alleviate human suffering by discovering long-acting antiviral therapeutics through innovative approaches.
Objectives
- To develop potent long-acting antiviral agents against HIV and SARS-CoV-2
- To develop multifunctional antiviral agents that display broad- spectrum activity
- To commercialize drugs with enhanced antiviral activity
- especially against multi-drug resistant virus
- cell-associated virus
- targeting hidden virus reservoirs